Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04139980 · ClinicalTrials.gov registry record · NA

Virtual Reality Device for Rehabilitation of Stroke Patients

A NA study of Stroke, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT04139980: Completed NA study of Stroke, sponsored by University of Alabama at Birmingham.

NCT04139980 is a NA study of Stroke that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04139980, a NA study of Stroke, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the potential efficacy and safety of using virtual reality gaming in conjunction to standard therapy regimen care as an approach to promote upper-limb motor recovery, cognitive function and quality of life after stroke. The investigators believe that allowing users to interact with a computer-simulated reality environment will result in a pleasant experience, which will likely result in motivation and therapy engagement.

Primary Outcome

National Institutes of Health Stroke Scale (NIHSS)

Conditions Studied

Interventions

  • OTHER Virtual Reality (VR)

Study Locations (1)

Alabama

  • UAB Spain Rehabilitation Center - Birmingham

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2020-01-01
Est. Completion 2020-03-03
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04139980 record still lists

NCT04139980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality (VR) is the first listed.

NCT04139980 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT04139980 about?

NCT04139980 is a clinical study titled "Virtual Reality Device for Rehabilitation of Stroke Patients". This study will evaluate the potential efficacy and safety of using virtual reality gaming in conjunction to standard therapy regimen care as an approach to promote upper-limb motor recovery, cognitive function and quality of life after stroke. The investigators believe that allowing users to intera...

What is the current status of trial NCT04139980?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-01-01. Estimated completion is 2020-03-03.

What conditions does trial NCT04139980 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04139980?

The interventions under investigation include: Virtual Reality (VR) (OTHER).

Who is sponsoring clinical trial NCT04139980?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04139980 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04139980's enrollment target sits among peer trials

5 439th of 454 higher than 11 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04139980, the US trial registry maintained by the National Library of Medicine. NCT04139980 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.